In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...
Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...
Clinical Trials Arena on MSN
Synthekine reports initial STK-012 data in lung cancer trial
Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed ...
We retrospectively analyzed the relationship between RARβ2 methylation and the SPLC development in a total of 342 NSCLCs. The methylation status of RARβ2 was determined by using methylation-specific ...
Credit: Getty Images The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more. The Global Initiative for ...
-- STK-012 is an <ALPHA>/<BETA> biased IL-2 designed to specifically stimulate antigen activated T cells -- Results from an ongoing Phase 1a/1b to be presented at SITC -- Company will also present new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback